Douglas Tremblay

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 10

Top Topics

Respiratory Syndrome Coronavirus

Chronic Myeloid Leukemia

Systematic Review

Tyrosine Kinase

Top Venues

Leukemia & lymphoma

Expert review of hematology

European journal of haematology

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Rachel Phelan, Annie Im, Rebecca L Hunter, Yoshihiro Inamoto, Maria Teresa Lupo-Stanghellini, Alicia Rovo, Sherif M Badawy, Linda J Burns, Hesham Eissa, Hemant S Murthy, Pinki Prasad, Akshay Sharma, Elizabeth M Suelzer, Vaibhav Agrawal, Mahmoud Aljurf, Karen Baker, Grzegorz Władysław Basak, David Buchbinder, Zachariah DeFilipp, Lana Desnica Grkovic, Ajoy Dias, Hermann Einsele, Michael L Eisenberg, Narendranath Epperla, Nosha Farhadfar, Arthur Flatau, Robert Peter Gale, Hildegard Greinix, Betty K Hamilton, Shahrukh Hashmi, Peiman Hematti, Kareem Jamani, Dipnarine Maharaj, John Murray, Seema G Naik, Sunita Nathan, Steven Pavletic, Zinaida Perić, Drazen Pulanic, Richard J Ross, Andrea Salonia, Isabel Sanchez-Ortega, Bipin N Savani, Tal Schechter, Ami J Shah, Stephanie M Smith, John A Snowden, Amir Steinberg, Douglas Tremblay, Sarah C Vij, Lauren Walker, Daniel Wolff, Jean A Yared, Hélène M Schoemans, André Tichelli
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Bone marrow transplantation 57 (7) (2022)
Douglas Tremblay, Joseph L Rapp, Naomi Alpert, Wil Lieberman-Cribbin, John Mascarenhas, Emanuela Taioli, Saghi Ghaffari
Mild anemia as a single independent predictor of mortality in patients with COVID-19. EJHaem (2021)
Douglas Tremblay, Naomi Alpert, Emanuela Taioli, John Mascarenhas
Prevalence of unexplained erythrocytosis and thrombocytosis - an NHANES analysis. Leukemia & lymphoma 62 (8) (2021)
Santiago Thibaud, Douglas Tremblay, Sheena Bhalla, Brittney Zimmerman, Keith Sigel, Janice Gabrilove
Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19. British journal of haematology 190 (2) (2020)
Leonard Naymagon, Douglas Tremblay, John O Mascarenhas
Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis. European journal of haematology 104 (4) (2020)
Jonathan Feld, Douglas Tremblay, Santiago Thibaud, Alaina J Kessler, Leonard Naymagon
Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis. International journal of laboratory hematology 42 (6) (2020)
Douglas Tremblay, Amber King, Lihua Li, Erin Moshier, Alexander Coltoff, Anita Koshy, Marina Kremyanskaya, Ronald Hoffman, Michael J Mauro, Raajit K Rampal, John Mascarenhas
Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis. Leukemia & lymphoma 61 (3) (2019)
Leonard Naymagon, Erin Moshier, Douglas Tremblay, John Mascarenhas
Predictors of early hemorrhage in acute promyelocytic leukemia. Leukemia & lymphoma 60 (10) (2019)
John O Mascarenhas, Maria R Baer, Craig Kessler, Elizabeth Hexner, Douglas Tremblay, Leah Price, Lonette Sandy, Rona Weinberg, Heike Pahl, Lewis R Silverman, Judith D Goldberg, Heidi Kosiorek, Amylou C Dueck, Ronald Hoffman
Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis. Leukemia & lymphoma 60 (5) (2019)
Douglas Tremblay, John Mascarenhas
Pacritinib to treat myelofibrosis patients with thrombocytopenia. Expert review of hematology 11 (9) (2018)